38 related articles for article (PubMed ID: 20030641)
1. Risk factors for sentinel lymph node metastasis in Korean acral and non-acral melanoma patients.
Song JY; Ryu YJ; Lee HK; Lee DH; Choi YD; Shim HJ; Yun SJ
Pigment Cell Melanoma Res; 2024 May; 37(3):332-342. PubMed ID: 38013393
[TBL] [Abstract][Full Text] [Related]
2. Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single-institutional cohort study.
Wagner NB; Knierim SM; Luttermann F; Metzler G; Yazdi AS; Bauer J; Gassenmaier M; Forschner A; Leiter U; Amaral T; Garbe C; Eigentler TK; Forchhammer S; Flatz L
J Am Acad Dermatol; 2024 Apr; 90(4):739-748. PubMed ID: 38043594
[TBL] [Abstract][Full Text] [Related]
3. Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression.
Park JY; Amankwah EK; Anic GM; Lin HY; Walls B; Park H; Krebs K; Madden M; Maddox K; Marzban S; Fang S; Chen W; Lee JE; Wei Q; Amos CI; Messina JL; Sondak VK; Sellers TA; Egan KM
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):827-34. PubMed ID: 23462921
[TBL] [Abstract][Full Text] [Related]
4. Fully Regressive Melanoma: A Case Without Metastasis.
Ehrsam E; Kallini JR; Lebas D; Khachemoune A; Modiano P; Cotten H
J Clin Aesthet Dermatol; 2016 Aug; 9(8):42-6. PubMed ID: 27672418
[TBL] [Abstract][Full Text] [Related]
5. Invasive Cutaneous Melanoma: Evaluating the Prognostic Significance of Some Parameters Associated with Lymph Node Metastases.
Vița O; Jurescu A; Văduva A; Cornea R; Cornianu M; Tăban S; Szilagyi D; Micșescu C; Natarâș B; Dema A
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512052
[No Abstract] [Full Text] [Related]
6. Predictive Values of Pathological and Clinical Risk Factors for Positivity of Sentinel Lymph Node Biopsy in Thin Melanoma: A Systematic Review and Meta-Analysis.
Huang H; Fu Z; Ji J; Huang J; Long X
Front Oncol; 2022; 12():817510. PubMed ID: 35155254
[TBL] [Abstract][Full Text] [Related]
7. Adequacy of sentinel lymph node biopsy in malignant melanoma of the trunk and extremities: Clinical observations regarding prognosis.
Bae YC; Jeong DK; Kim KH; Nam KW; Kim GW; Kim HS; Nam SB; Bae SH
Arch Plast Surg; 2020 Jan; 47(1):42-48. PubMed ID: 31964122
[TBL] [Abstract][Full Text] [Related]
8. Complete lymphadenectomy following positive sentinel lymph node biopsy in cutaneous melanoma: a critical review.
Eiger D; Oliveira DA; Oliveira RL; Sousa MC; Brandão MDC; Oliveira Filho RS
An Bras Dermatol; 2018; 93(4):553-558. PubMed ID: 30066763
[TBL] [Abstract][Full Text] [Related]
9. Regression and Sentinel Lymph Node Status in Melanoma Progression.
Letca AF; Ungureanu L; Şenilă SC; Grigore LE; Pop Ş; Fechete O; Vesa ŞC; Cosgarea R
Med Sci Monit; 2018 Mar; 24():1359-1365. PubMed ID: 29507279
[TBL] [Abstract][Full Text] [Related]
10. Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance.
Aung PP; Nagarajan P; Prieto VG
Lab Invest; 2017 Jun; 97(6):657-668. PubMed ID: 28240749
[TBL] [Abstract][Full Text] [Related]
11. Variations in the expression of TIMP1, TIMP2 and TIMP3 in cutaneous melanoma with regression and their possible function as prognostic predictors.
Zurac S; Neagu M; Constantin C; Cioplea M; Nedelcu R; Bastian A; Popp C; Nichita L; Andrei R; Tebeica T; Tanase C; Chitu V; Caruntu C; Ghita M; Popescu C; Boda D; Mastalier B; Maru N; Daha C; Andreescu B; Marinescu I; Rebosapca A; Staniceanu F; Negroiu G; Ion DA; Nikitovic D; Tzanakakis GN; Spandidos DA; Tsatsakis AM
Oncol Lett; 2016 May; 11(5):3354-3360. PubMed ID: 27123116
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival analysis and clinical follow-up in acral lentiginous malignant melanoma undergoing sentinel lymph node biopsy in korean patients.
Jeon SY; Hong JW; Lee S; Oh SY; Hong YS; Kim KH; Song KH
Ann Dermatol; 2014 Apr; 26(2):177-83. PubMed ID: 24882971
[TBL] [Abstract][Full Text] [Related]
13. Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanoma.
McClain SE; Shada AL; Barry M; Patterson JW; Slingluff CL
Melanoma Res; 2012 Aug; 22(4):302-9. PubMed ID: 22610274
[TBL] [Abstract][Full Text] [Related]
14. Histological regression in primary melanoma: not a predictor of sentinel lymph node metastasis in a cohort of 397 patients.
Socrier Y; Lauwers-Cances V; Lamant L; Garrido I; Lauwers F; Lopez R; Rochaix P; Chevreau C; Payoux P; Viraben R; Paul C; Meyer N
Br J Dermatol; 2010 Apr; 162(4):830-4. PubMed ID: 20030641
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
[TBL] [Abstract][Full Text] [Related]
16. Tumour regression does not increase the risk of sentinel node involvement in thin melanomas.
Cecchi R; Pavesi M; Buralli L; Innocenti S; De Gaudio C
Chir Ital; 2008; 60(2):257-60. PubMed ID: 18689175
[TBL] [Abstract][Full Text] [Related]
17. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
18. Mitotic rate for thin melanomas: should a single mitotic figure warrant a sentinel lymph node biopsy?
Kirkland EB; Zitelli JA
Dermatol Surg; 2014 Sep; 40(9):937-45. PubMed ID: 25072127
[TBL] [Abstract][Full Text] [Related]
19. Regression of primary melanoma with metastases.
Avril MF; Charpentier P; Margulis A; Guillaume JC
Cancer; 1992 Mar; 69(6):1377-81. PubMed ID: 1540876
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
